A meta-analysis published in 2023 showed that positive anti-Ro52 is associated with a higher frequency of ILD diagnosis in various autoimmune diseases and is also related to more severe lung lesions (RP–ILD) (30). The gene discussed is TRIM21; the disease is interstitial lung disease.